| Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms DE Gordon, J Hiatt, M Bouhaddou, VV Rezelj, S Ulferts, H Braberg, ... Science 370 (6521), eabe9403, 2020 | 626 | 2020 |
| Propagation, inactivation, and safety testing of SARS-CoV-2 AS Jureka, JA Silvas, CF Basler Viruses 12 (6), 622, 2020 | 139 | 2020 |
| Structural basis for a novel interaction between the NS1 protein derived from the 1918 influenza virus and RIG-I AS Jureka, AB Kleinpeter, G Cornilescu, CC Cornilescu, CM Petit Structure 23 (11), 2001-2010, 2015 | 58 | 2015 |
| Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication CG Williams, AS Jureka, JA Silvas, AM Nicolini, SA Chvatal, ... Cell reports 36 (5), 2021 | 56 | 2021 |
| The influenza NS1 protein modulates RIG-I activation via a strain-specific direct interaction with the second CARD of RIG-I AS Jureka, AB Kleinpeter, JL Tipper, KS Harrod, CM Petit Journal of Biological Chemistry 295 (4), 1153-1164, 2020 | 46 | 2020 |
| Influenza-induced oxidative stress sensitizes lung cells to bacterial-toxin-mediated necroptosis N Gonzalez-Juarbe, AN Riegler, AS Jureka, RP Gilley, JD Brand, ... Cell reports 32 (8), 2020 | 35 | 2020 |
| Inhibitors of VPS34 and lipid metabolism suppress SARS-CoV-2 replication JA Silvas, AS Jureka, AM Nicolini, SA Chvatal, CF Basler Biorxiv, 2020 | 32 | 2020 |
| HLA class-II associated HIV polymorphisms predict escape from CD4+ T cell responses N Erdmann, VY Du, J Carlson, M Schaefer, A Jureka, S Sterrett, L Yue, ... PLoS pathogens 11 (8), e1005111, 2015 | 30 | 2015 |
| Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compounds AB Kleinpeter, AS Jureka, SM Falahat, TJ Green, CM Petit Journal of Biological Chemistry 293 (38), 14659-14668, 2018 | 27 | 2018 |
| Pulsed broad-spectrum UV light effectively inactivates SARS-CoV-2 on multiple surfaces and N95 material AS Jureka, CG Williams, CF Basler Viruses 13 (3), 460, 2021 | 19 | 2021 |
| Synthesis and antiviral activity of fatty acyl conjugates of remdesivir against severe acute respiratory syndrome coronavirus 2 and Ebola virus NS El-Sayed, AS Jureka, MR Edwards, S Lohan, CG Williams, PT Keiser, ... European Journal of Medicinal Chemistry 226, 113862, 2021 | 10 | 2021 |
| Propagation, inactivation, and safety testing of SARS-CoV-2. Viruses 12: 622 AS Jureka, JA Silvas, CF Basler | 10 | 2020 |
| .(2020) Comparative host-coronavirus protein interaction networks reveal panviral disease mechanisms DE Gordon, J Hiatt, M Bouhaddou, VV Rezelj, S Ulferts, H Braberg, ... Science 370, 370, 0 | 9 | |
| Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets KM Haas, MJ McGregor, M Bouhaddou, BJ Polacco, EY Kim, TT Nguyen, ... Nature communications 14 (1), 6030, 2023 | 8 | 2023 |
| Propagation and Quantification of SARS-CoV-2 AS Jureka, CF Basler SARS-CoV-2: Methods and Protocols, 111-129, 2022 | 3 | 2022 |
| Structural investigations of interactions between the influenza a virus NS1 and host cellular proteins ME Blake, AB Kleinpeter, AS Jureka, CM Petit Viruses 15 (10), 2063, 2023 | 1 | 2023 |
| Propagation, inactivation, and safety testing of SARS-CoV-2 (preprint) AS Jureka, JA Silvas, CF Basler | 1 | 2020 |
| Methods for screening novel coronavirus antivirals and methods of using antivirals for the treatment of coronavirus infections CF Basler, J Silvas, A Jureka US Patent App. 18/015,880, 2023 | | 2023 |
| Pulsed broad-spectrum UV light effectively inactivates SARS-CoV-2 on multiple surfaces (preprint) AS Jureka, CG Williams, CF Basler | | 2021 |
| Inhibitors of VPS34 and lipid metabolism suppress SARS-CoV-2 replication (preprint) JA Silvas, AS Jureka, AM Nicolini, SA Chvatal, CF Basler | | 2020 |
